EyePoint, Inc (EYPT)

EyePoint, Inc (EYPT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $34M; returns 1 day -5.5%, 1 week -86.5%, 1 year -96.5%.

EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative ophthalmic therapies for serious eye conditions. EyePoint specializes in sustained-release therapeutics, primarily targeting chronic eye diseases such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

Groups EYPT belongs to

• Biotechnology
• Ophthalmology
• Clinical Stage Biopharma
• Healthcare
• Clinical Stage Biotech
• Pharmaceuticals
• Life Sciences
• Biopharmaceutical
• Chronic Disease Management
• Drug Discovery

EYPT financial model: income statement, cash flow and balance sheet